Associations between adiposity, hormones, and gains in height, whole-body height-adjusted bone size, and size-adjusted bone mineral content in 8- to 11-year-old children

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningfagfællebedømt

Standard

Associations between adiposity, hormones, and gains in height, whole-body height-adjusted bone size, and size-adjusted bone mineral content in 8- to 11-year-old children. / Dalskov, Stine-Mathilde; Ritz, Christian; Larnkjær, Anni; Damsgaard, Camilla Trab; Petersen, Rikke Agnete; Sørensen, Louise Bergmann; Ong, Ken K; Astrup, Arne; Michaelsen, Kim F.; Mølgaard, Christian.

I: Osteoporosis International, Bind 27, Nr. 4, 2016, s. 1619-1629.

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningfagfællebedømt

Harvard

Dalskov, S-M, Ritz, C, Larnkjær, A, Damsgaard, CT, Petersen, RA, Sørensen, LB, Ong, KK, Astrup, A, Michaelsen, KF & Mølgaard, C 2016, 'Associations between adiposity, hormones, and gains in height, whole-body height-adjusted bone size, and size-adjusted bone mineral content in 8- to 11-year-old children', Osteoporosis International, bind 27, nr. 4, s. 1619-1629. https://doi.org/10.1007/s00198-015-3428-z

APA

Dalskov, S-M., Ritz, C., Larnkjær, A., Damsgaard, C. T., Petersen, R. A., Sørensen, L. B., Ong, K. K., Astrup, A., Michaelsen, K. F., & Mølgaard, C. (2016). Associations between adiposity, hormones, and gains in height, whole-body height-adjusted bone size, and size-adjusted bone mineral content in 8- to 11-year-old children. Osteoporosis International, 27(4), 1619-1629. https://doi.org/10.1007/s00198-015-3428-z

Vancouver

Dalskov S-M, Ritz C, Larnkjær A, Damsgaard CT, Petersen RA, Sørensen LB o.a. Associations between adiposity, hormones, and gains in height, whole-body height-adjusted bone size, and size-adjusted bone mineral content in 8- to 11-year-old children. Osteoporosis International. 2016;27(4):1619-1629. https://doi.org/10.1007/s00198-015-3428-z

Author

Dalskov, Stine-Mathilde ; Ritz, Christian ; Larnkjær, Anni ; Damsgaard, Camilla Trab ; Petersen, Rikke Agnete ; Sørensen, Louise Bergmann ; Ong, Ken K ; Astrup, Arne ; Michaelsen, Kim F. ; Mølgaard, Christian. / Associations between adiposity, hormones, and gains in height, whole-body height-adjusted bone size, and size-adjusted bone mineral content in 8- to 11-year-old children. I: Osteoporosis International. 2016 ; Bind 27, Nr. 4. s. 1619-1629.

Bibtex

@article{d08bdfb8ef9f4a27a7fc5bd1a33552b2,
title = "Associations between adiposity, hormones, and gains in height, whole-body height-adjusted bone size, and size-adjusted bone mineral content in 8- to 11-year-old children",
abstract = "We examined fat-independent associations of hormones with height and whole-body bone size and mineral content in 633 school children. IGF-1 and osteocalcin predict growth in height, while fat, osteocalcin, and in girls also, IGF-1 predict growth in bone size. Leptin and ghrelin are inversely associated with bone size in girls.INTRODUCTION: Obesity causes larger bone size and bone mass, but the role of hormones in this up-regulation of bone in obesity is not well elucidated. We examined longitudinal associations between baseline body fat mass (FM), and fat-independent fasting levels of ghrelin, adiponectin, leptin, insulin, insulin-like growth factor-I (IGF-1), osteocalcin, and intact parathyroid hormone, and subsequent changes in height and in whole-body height-adjusted bone area {"}BAheight{"} and size-adjusted bone mineral content {"}BMCsize{"} in 8- to 11-year-olds.METHODS: Analyses were carried out separately for boys (n = 325) and girls (n = 308) including data from baseline, 3 and 6 months from OPUS School Meal Study.RESULTS: In both sexes: gain in BAheight was positively associated with baseline FM (≥2.05 cm(2)/kg, both p ≤ 0.003). Furthermore, gain in height was positively associated with baseline IGF-1 (≥0.02 cm/ng/ml, p = 0.001) and osteocalcin (≥0.13 cm/ng/ml, p ≤ 0.009); and gain in BAheight was positively associated with baseline osteocalcin (≥0.35 cm(2)/ng/ml, p ≤ 0.019). In girls only, gain in BAheight was also positively associated with baseline IGF-1 (0.06 cm(2)/ng/ml, p = 0.017) and inversely associated with both baseline ghrelin (-0.01 cm(2)/pg/ml, p = 0.001) and leptin (-1.21 cm(2)/μg/ml, p = 0.005). In boys, gain in BMCsize was positively associated with osteocalcin (0.18 g/ng/ml, p = 0.030).CONCLUSIONS: This large longitudinal study suggests that in 8- to 11-year-old children, IGF-1 and osteocalcin predict growth in height, while FM, osteocalcin, and in girls also, IGF-1 predict growth in BAheight. Fat-independent inverse associations of leptin and ghrelin with BAheight in girls' are contrary to proposed growth-stimulating effects of leptin. Osteocalcin in boys predicts gain in BMCsize.",
author = "Stine-Mathilde Dalskov and Christian Ritz and Anni Larnkj{\ae}r and Damsgaard, {Camilla Trab} and Petersen, {Rikke Agnete} and S{\o}rensen, {Louise Bergmann} and Ong, {Ken K} and Arne Astrup and Michaelsen, {Kim F.} and Christian M{\o}lgaard",
note = "CURIS 2016 NEXS 018",
year = "2016",
doi = "10.1007/s00198-015-3428-z",
language = "English",
volume = "27",
pages = "1619--1629",
journal = "Osteoporosis International",
issn = "0937-941X",
publisher = "Springer",
number = "4",

}

RIS

TY - JOUR

T1 - Associations between adiposity, hormones, and gains in height, whole-body height-adjusted bone size, and size-adjusted bone mineral content in 8- to 11-year-old children

AU - Dalskov, Stine-Mathilde

AU - Ritz, Christian

AU - Larnkjær, Anni

AU - Damsgaard, Camilla Trab

AU - Petersen, Rikke Agnete

AU - Sørensen, Louise Bergmann

AU - Ong, Ken K

AU - Astrup, Arne

AU - Michaelsen, Kim F.

AU - Mølgaard, Christian

N1 - CURIS 2016 NEXS 018

PY - 2016

Y1 - 2016

N2 - We examined fat-independent associations of hormones with height and whole-body bone size and mineral content in 633 school children. IGF-1 and osteocalcin predict growth in height, while fat, osteocalcin, and in girls also, IGF-1 predict growth in bone size. Leptin and ghrelin are inversely associated with bone size in girls.INTRODUCTION: Obesity causes larger bone size and bone mass, but the role of hormones in this up-regulation of bone in obesity is not well elucidated. We examined longitudinal associations between baseline body fat mass (FM), and fat-independent fasting levels of ghrelin, adiponectin, leptin, insulin, insulin-like growth factor-I (IGF-1), osteocalcin, and intact parathyroid hormone, and subsequent changes in height and in whole-body height-adjusted bone area "BAheight" and size-adjusted bone mineral content "BMCsize" in 8- to 11-year-olds.METHODS: Analyses were carried out separately for boys (n = 325) and girls (n = 308) including data from baseline, 3 and 6 months from OPUS School Meal Study.RESULTS: In both sexes: gain in BAheight was positively associated with baseline FM (≥2.05 cm(2)/kg, both p ≤ 0.003). Furthermore, gain in height was positively associated with baseline IGF-1 (≥0.02 cm/ng/ml, p = 0.001) and osteocalcin (≥0.13 cm/ng/ml, p ≤ 0.009); and gain in BAheight was positively associated with baseline osteocalcin (≥0.35 cm(2)/ng/ml, p ≤ 0.019). In girls only, gain in BAheight was also positively associated with baseline IGF-1 (0.06 cm(2)/ng/ml, p = 0.017) and inversely associated with both baseline ghrelin (-0.01 cm(2)/pg/ml, p = 0.001) and leptin (-1.21 cm(2)/μg/ml, p = 0.005). In boys, gain in BMCsize was positively associated with osteocalcin (0.18 g/ng/ml, p = 0.030).CONCLUSIONS: This large longitudinal study suggests that in 8- to 11-year-old children, IGF-1 and osteocalcin predict growth in height, while FM, osteocalcin, and in girls also, IGF-1 predict growth in BAheight. Fat-independent inverse associations of leptin and ghrelin with BAheight in girls' are contrary to proposed growth-stimulating effects of leptin. Osteocalcin in boys predicts gain in BMCsize.

AB - We examined fat-independent associations of hormones with height and whole-body bone size and mineral content in 633 school children. IGF-1 and osteocalcin predict growth in height, while fat, osteocalcin, and in girls also, IGF-1 predict growth in bone size. Leptin and ghrelin are inversely associated with bone size in girls.INTRODUCTION: Obesity causes larger bone size and bone mass, but the role of hormones in this up-regulation of bone in obesity is not well elucidated. We examined longitudinal associations between baseline body fat mass (FM), and fat-independent fasting levels of ghrelin, adiponectin, leptin, insulin, insulin-like growth factor-I (IGF-1), osteocalcin, and intact parathyroid hormone, and subsequent changes in height and in whole-body height-adjusted bone area "BAheight" and size-adjusted bone mineral content "BMCsize" in 8- to 11-year-olds.METHODS: Analyses were carried out separately for boys (n = 325) and girls (n = 308) including data from baseline, 3 and 6 months from OPUS School Meal Study.RESULTS: In both sexes: gain in BAheight was positively associated with baseline FM (≥2.05 cm(2)/kg, both p ≤ 0.003). Furthermore, gain in height was positively associated with baseline IGF-1 (≥0.02 cm/ng/ml, p = 0.001) and osteocalcin (≥0.13 cm/ng/ml, p ≤ 0.009); and gain in BAheight was positively associated with baseline osteocalcin (≥0.35 cm(2)/ng/ml, p ≤ 0.019). In girls only, gain in BAheight was also positively associated with baseline IGF-1 (0.06 cm(2)/ng/ml, p = 0.017) and inversely associated with both baseline ghrelin (-0.01 cm(2)/pg/ml, p = 0.001) and leptin (-1.21 cm(2)/μg/ml, p = 0.005). In boys, gain in BMCsize was positively associated with osteocalcin (0.18 g/ng/ml, p = 0.030).CONCLUSIONS: This large longitudinal study suggests that in 8- to 11-year-old children, IGF-1 and osteocalcin predict growth in height, while FM, osteocalcin, and in girls also, IGF-1 predict growth in BAheight. Fat-independent inverse associations of leptin and ghrelin with BAheight in girls' are contrary to proposed growth-stimulating effects of leptin. Osteocalcin in boys predicts gain in BMCsize.

U2 - 10.1007/s00198-015-3428-z

DO - 10.1007/s00198-015-3428-z

M3 - Journal article

C2 - 26667245

VL - 27

SP - 1619

EP - 1629

JO - Osteoporosis International

JF - Osteoporosis International

SN - 0937-941X

IS - 4

ER -

ID: 152990601